Systemic cytokines related to memory function 6–9 months and 12–15 months after SARS-CoV-2 infection

A. Nuber-Champier,G. Breville,P. Voruz,I. Jacot de Alcântara,A. Cionca,G. Allali,P. H. Lalive,L. Benzakour,K.-O. Lövblad,O. Braillard,M. Nehme,M. Coen,J. Serratrice,J.-L. Reny,J. Pugin,I. Guessous,B. N. Landis,F. Assal,Julie Anne Péron

DOI: https://doi.org/10.1038/s41598-024-72421-z

IF: 4.6

2024-10-02

Scientific Reports

Abstract:Cognitive symptoms persisting beyond the acute phase of COVID-19 infection are commonly described for up to 2 years after infection. The relationship between cognitive performance, in particular episodic memory processes observed chronically after infection, and cytokine levels in the acute phase of COVID-19 has not yet been identified in humans. To determine whether the levels of cytokines IL1β, IL-6 and TNFα secreted in the acute phase of SARS-CoV-2 infection are associated and predict verbal and visuospatial episodic memory performance in humans 6 to 9 months and 12 to 15 months post-infection. The associations and predictive value of the concentration of cytokines measured in acute phase (IL-1β, IL-6, TNFα) from plasma samples of N = 33 hospitalized COVID-19 patients (mean age 61 years, 39–78, 65% in intensive care) in relation to their verbal and visuospatial episodic memory performance measured at 6–9 months and 12–15 months post-infection were analyzed. To do this, we used Spearman correlations and generalised linear mixed models. IL-1β levels were associated with verbal episodic memory total recall scores 6–9 months post-infection. At 12–15 months post-infection IL-6 predicted verbal episodic memory score. This study demonstrated that the severity of inflammatory reaction at acute phase of SARS-CoV-2 infection predicts verbal episodic memory performance in the long-term post-infection.

multidisciplinary sciences